Is CureVac N.V. (5CV.F) a Buy, Sell, or Hold?
FSX : 5CV.F
CureVac N.V.
$3.906 EUR
$0 (0.0%)
- Volume
- 22.09K
- Average Volume
- 14.58K
- Market Capitalization
- $879.52M
- P/E Ratio
- 5.43
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $4.92
- Year Low
- $2.15
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.70
Company Overview
FSX
Alexander Zehnder
Biotechnology
Healthcare
5CV.F
825
DE
EUR
Liquidity Metrics
0.04
3.70
3.69
1.76
0.00
Sales & Valuation
$535.18M
15.63
1.01
-15.72
-0.25
Profitability
$0.72
$162.19M
287.15%
348.24%
23.04%
14.19%
P/E Metrics
5.43
0.39
0.39
Analyst Price Target & Rating
0/5
8 Analysts
%
Financial Health Scores
1.65
3/9
$636.94M
$1.14B
$267.39M
$163.58M
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Marco Rau | General Counsel |
| Thaminda Ramanayake | Chief Business Officer & Member of Executive Board |
| Slavica Stevanovic-Heck | Head of Human Resources |
| Myriam Mendila | Chief Scientific Officer, Head of R&D, MD & Member of the Management Board |
| Axel-Sven Malkomes | Chief Financial Officer & Member of Executive Board |
| Malte Greune | Chief Operating Officer, Member of Management Board & MD |
| Sarah Fakih | Vice President of Corporate Communications & Investor Relations |
| Ulrike Gnad-Vogt | Senior Vice President & Area Head of Oncology |
| Patrick Baumhof | Senior Vice President of Technology |
| Alexander Zehnder | Chief Executive Officer, MD & Member of Management Board |
Poll Results
No votes yet today — be the first to share your view!
About CureVac N.V. (FSX:5CV.F) Stock
CureVac N.V. is a clinical-stage biopharmaceutical enterprise focused on developing revolutionary therapeutic solutions based on messenger ribonucleic acid (mRNA) technology. The company's portfolio includes various prophylactic mRNA-based vaccine candidates. For instance, CV2CoV is currently undergoing Phase 1 clinical trials for SARS-CoV-2, while CVSQIV is in Phase 1 development against influenza. Their CV7202 vaccine, designed to combat rabies virus glycoprotein, has already completed Phase 1 clinical evaluation. Additionally, CureVac is advancing vaccines for Lassa fever, yellow fever, respiratory syncytial virus, rotavirus, malaria, and universal influenza. Beyond vaccines, the firm is also innovating RNA-based immunotherapies for cancer, with CV8102 in Phase 1 clinical investigation ... for treating cutaneous melanoma, adenoidcystic carcinoma, and squamous cell carcinoma of the skin, head, and neck. Founded in 2000, CureVac N.V. is headquartered in Tübingen, Germany.
Frequently Asked Questions
-
What is the current CureVac N.V. (5CV.F) stock price?
-
CureVac N.V.(FSX:5CV.F) stock price is $3.906 in the last trading session. During the trading session, 5CV.F stock reached the peak price of $4.916 while $2.15 was the lowest point it dropped to. The percentage change in 5CV.F stock occurred in the recent session was 0.0% while the dollar amount for the price change in 5CV.F stock was $0.
-
5CV.F's industry and sector of operation?
-
The FSX listed 5CV.F is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of 5CV.F?
-
Marco Rau | General Counsel
Thaminda Ramanayake | Chief Business Officer & Member of Executive Board
Slavica Stevanovic-Heck | Head of Human Resources
Myriam Mendila | Chief Scientific Officer, Head of R&D, MD & Member of the Management Board
Axel-Sven Malkomes | Chief Financial Officer & Member of Executive Board -
How many employees does 5CV.F have?
-
Number of 5CV.F employees currently stands at 825. 5CV.F operates from Friedrich-Miescher-Strasse 15, Tübingen, None 72076, DE.
-
Link for 5CV.F official website?
-
Official Website of 5CV.F is: https://www.curevac.com
-
How do I contact 5CV.F?
-
5CV.F could be contacted at phone #49 7071 9883 0 and can also be accessed through its website. 5CV.F operates from Friedrich-Miescher-Strasse 15, Tübingen, None 72076, DE.
-
How many shares of 5CV.F are traded daily?
-
The average number of 5CV.F shares traded daily for last 3 months was 14.58K.
-
What is the market cap of 5CV.F currently?
-
The market value of 5CV.F currently stands at $879.52M with its latest stock price at $3.906